Ani pharmaceuticals announces presentation of preclinical data on the use of purified cortrophin® gel in an experimental autoimmune uveitis (eau) mouse model

Demonstrated dose dependent effect in eau presented in a podium presentation at the association for research in vision and ophthalmology (arvo) 2025 annual meeting princeton, n.j., may 05, 2025 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced preclinical data on the use of purified cortrophin® gel (repository corticotropin injection usp) (cortrophin gel) in an eau mouse model.
ANIP Ratings Summary
ANIP Quant Ranking